Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-25-106669
Filing Date
2025-11-05
Accepted
2025-11-05 16:24:35
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea0264131-424b3_oruka.htm 424B3 211554
2 GRAPHIC image_001.jpg GRAPHIC 12309
  Complete submission text file 0001213900-25-106669.txt   229946
Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025
Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910
Oruka Therapeutics, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-290715 | Film No.: 251454452
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)